Regulations.gov document
Draft Guidance on Medroxyprogesterone Acetate - PSG_012541
Other · FDA-2007-D-0369 · posted Aug 5, 2022
Key facts
| Document ID | FDA-2007-D-0369-0640 |
|---|---|
| Title | Draft Guidance on Medroxyprogesterone Acetate - PSG_012541 |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2007-D-0369 |
| Posted | Aug 5, 2022 |
| Comment period opens | Aug 5, 2022 |
| Comments due | Oct 4, 2022 |
At a glance
- No Open for comment
- 100–999 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: